Patents by Inventor Russell Garlick

Russell Garlick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220178939
    Abstract: Disclosed are controls for use in identifying any of a number of genotypes and/or for use in identifying or characterizing a disease or condition. The controls may be particularly useful for diagnostic tests that utilize circulating cell-free DNA or microRNA. A control may comprise a mixture of nucleic acids. In some embodiments, a control comprises liposomes, e.g., wherein nucleic acids of the control are associated with the liposomes. For example, the controls are useful for determining whether a fetus comprises an aneuploidy. Also disclosed are methods of using the controls.
    Type: Application
    Filed: December 16, 2021
    Publication date: June 9, 2022
    Inventors: Bharathi Anekella, Russell Garlick, Catherine Huang, Seth Harkins, Yves Konigshofer, Aice Ku, Farol Tomson
  • Patent number: 11243212
    Abstract: Disclosed are controls for use in identifying any of a number of genotypes and/or for use in identifying or characterizing a disease or condition. The controls may be particularly useful for diagnostic tests that utilize circulating cell-free DNA or microRNA. A control may comprise a mixture of nucleic acids. In some embodiments, a control comprises liposomes, e.g., wherein nucleic acids of the control are associated with the liposomes. For example, the controls are useful for determining whether a fetus comprises an aneuploidy. Also disclosed are methods of using the controls.
    Type: Grant
    Filed: May 6, 2016
    Date of Patent: February 8, 2022
    Assignee: SeraCare Life Sciences, Inc.
    Inventors: Bharathi Anekella, Russell Garlick, Catherine Huang, Seth Harkins, Yves Konigshofer, Alice Ku, Farol Tomson
  • Publication number: 20210254020
    Abstract: Disclosed are compositions and methods related to replication deficient Sindbis viruses that are able to function as controls for nucleic acid diagnostic assays (e.g., nucleic acid sequencing based assays and/or nucleic acid amplification based assays).
    Type: Application
    Filed: February 22, 2021
    Publication date: August 19, 2021
    Inventors: Russell Garlick, Catherine Huang, Bharathi Anekella, Jonathan Li
  • Publication number: 20190002838
    Abstract: Disclosed are compositions and methods related to replication deficient Sindbis viruses that are able to function as controls for nucleic acid diagnostic assays (e.g., nucleic acid sequencing based assays and/or nucleic acid amplification based assays).
    Type: Application
    Filed: June 3, 2016
    Publication date: January 3, 2019
    Inventors: Russell Garlick, Catherine Huang, Bharathi Anekella, Jonathan Li
  • Publication number: 20180149660
    Abstract: Disclosed are controls for use in identifying any of a number of genotypes and/or for use in identifying or characterizing a disease or condition. The controls may be particularly useful for diagnostic tests that utilize circulating cell-free DNA or microRNA. A control may comprise a mixture of nucleic acids. In some embodiments, a control comprises liposomes, e.g., wherein nucleic acids of the control are associated with the liposomes. For example, the controls are useful for determining whether a fetus comprises an aneuploidy. Also disclosed are methods of using the controls.
    Type: Application
    Filed: May 6, 2016
    Publication date: May 31, 2018
    Inventors: Bharathi Anekella, Russell Garlick, Catherine Huang, Seth Harkins, Yves Konigshofer, Alice Ku, Farol Tomson